UK peptide regulation in 2024: what RUO actually means, and where the legal boundaries sit
A dated overview of research-use-only supply in the UK and why labelling alone does not determine legal compliance.
Scope of this report
This report records the editorial team’s understanding of the UK position in 2024. It is not legal advice and should not be treated as a current regulatory opinion. Laws, guidance and enforcement practice can change.
What research use only means
A research-use-only label describes the intended laboratory context; it is not a shortcut around product classification, medicinal-presentation rules or other legal duties. Marketing language, instructions, customer journey and actual supply practices all matter.
Presentation and conduct
A compliant catalogue avoids therapeutic claims, dosing information and content that encourages personal use. Research-only language should appear consistently before purchase, at checkout and in order communications.
Before relying on this report
Obtain current advice from a UK solicitor familiar with medicines, consumer protection and e-commerce. The Compound Index treats that review as a launch dependency, not an editorial substitute.